Incidence of Unanticipated Uterine Pathology at the Time of Minimally Invasive Abdominal Sacrocolpopexy

Abstract

Study ObjectiveTo determine the incidence of unanticipated uterine pathologic findings in women undergoing hysterectomy concomitant with minimally invasive sacrocolpopexy. DesignRetrospective case series (Canadian Task Force classification III). SettingFour institutions in the United States. PatientsWomen undergoing laparoscopic or robotically assisted sacrocolpopexy with hysterectomy. InterventionsConcurrent hysterectomy and minimally invasive sacrocolpopexy. Measurements and Main ResultsWe measured the incidence of clinically important uterine disease at minimally invasive sacrocolpopexy. A total of 324 women underwent concurrent hysterectomy and minimally invasive sacrocolpopexy. Their mean age was 56.1 years, and body mass index was 26.9 kg/m2. Sixty-four percent were postmenopausal. Only 3 patients (0.92%) had abnormal uterine pathologic findings. No significant differences were noted in age, body mass index, or parity between the women with normal and abnormal uterine pathologic findings. None of the 3 women reported abnormal uterine bleeding before surgery. All lesions were premalignant and focal. No invasive carcinomas were identified. No patients required further follow-up or treatment of abnormal pathologic findings. ConclusionThe risk of unanticipated uterine pathologic findings during minimally invasive sacrocolpopexy to treat pelvic organ prolapse is low.